07.03.26 -- Achieving Annex 1 Compliance In Sterile Manufacturing, Part 1: Common Compliance Failures

As drug modalities grow more complex, speed depends on smarter decisions. See how bioprocessing equipment choices play a larger role in enabling momentum than many teams realize.

Sterile manufacturing remains vital, with resilient supply chains preventing shortages. Industry and regulators prioritize integrity as demand surges, making it the fastest-growing pharmaceutical segment.

Explore strategies to solve solubility and permeability challenges, boost oral bioavailability, and ensure consistent absorption — reducing risk and unlocking complex molecules.

Gain insight into how an innovative Liver-Chip S1 revolutionizes predictive toxicology by mimicking human liver biology, achieving superior sensitivity and specificity.

Structure‑enabled drug discovery revealed a novel, druggable binding site in Artemis, enabling rapid SAR optimization and a ~500‑fold potency improvement against a challenging oncology target.

Polymorphism impacts solubility, stability, and manufacturability, making early solid‑form screening critical to reduce risk, guide development decisions, and ensure consistent performance.

Accurate TOC results shouldn’t depend on sample order. Discover how low-level measurements remain reliable even after high-TOC analysis, helping reduce false positives and streamline decisions.

Agentic AI delivers real value only when supported by contextualized data. Examine how unified data fabrics transform siloed records into actionable intelligence, enabling faster, more reliable decisions.

Precision inspection and compliance-driven processes are essential for manufacturing to help safeguard product quality, support regulatory requirements, and protect patient safety at scale.